Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

Background. Concomitant use of rifamycins to treat or prevent tuberculosis can result in subtherapeutic concentrations of antiretroviral drugs. We studied the interaction of efavirenz with daily rifapentine and isoniazid in human immunodeficiency virus (HIV)–infected individuals receiving a 4-week r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Podany, Anthony T., Bao, Yajing, Swindells, Susan, Chaisson, Richard E., Andersen, Janet W., Mwelase, Thando, Supparatpinyo, Khuanchai, Mohapi, Lerato, Gupta, Amita, Benson, Constance A., Kim, Peter, Fletcher, Courtney V.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
HIV/AIDS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4583578/
https://ncbi.nlm.nih.gov/pubmed/26082504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ464
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars